The aim of this study is to examine the therapeutic effectiveness of two different exercise frequencies of high-intensity interval training (HIIT; once versus thrice weekly, with matched weekly exercise volume) on improving cardiometabolic risk factors in centrally obese adults.
HIIT is an emerging, popular, promising, cost-effective, and time-efficient exercise modality for managing obesity. Although lower-frequency HIIT is favorable for intervention adherence, the optimal exercise frequency of HIIT for alleviating obesity is unknown. This study is a three-arm randomized controlled trial. Centrally obese adults will be randomly allocated to three groups: the usual care control, once and thrice-weekly HIIT groups. Led by research personnel, the usual care group will receive obesity-related health education. Led by athletic coaches, the HIIT intervention groups will receive 16 weeks of once or thrice weekly HIIT (with matched weekly exercise volume). Outcome measures of this study will be examined at baseline, 4 months (post-intervention), and 8 months (follow-up), by assessors blinded to group allocation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
315
Participants in this group will receive a 16-week intervention of HIIT once weekly supervised by certified athletic coaches. Participants will perform four 4-minute intervals at 85%-95% peak heart rate with a 3-minute active recovery between each 4-minute interval. Participants will repeat the 25-minute HIIT bout three times with 30-60 minutes break in between each 25-minute HIIT bout. Health information provided to the usual care control group will be made available to the participants in the HIIT groups.
Participants in this group will receive a 16-week intervention of HIIT thrice weekly supervised by certified athletic coaches. Participants will perform four 4-minute intervals at 85%-95% peak heart rate with a 3-minute active recovery between each 4-minute interval. Health information provided to the usual care control group will be made available to the participants in the HIIT groups.
LKS Faculty of Medicine
Hong Kong, Hong Kong
Change in Body Fat
Total body fat mass will be assessed using dual-energy X-ray absorptiometry (DXA)
Time frame: Baseline and 4 months
Change in Body Fat
Total body fat mass will be assessed using dual-energy X-ray absorptiometry (DXA)
Time frame: Baseline and 8 months
Change in Abdominal Visceral Fat
Abdominal visceral fat will be assessed using magnetic resonance imaging (MRI)
Time frame: Baseline and 4 and 8 months
Change in Abdominal Subcutaneous Fat
Abdominal subcutaneous fat will be assessed using magnetic resonance imaging (MRI)
Time frame: Baseline and 4 and 8 months
Change in Body Mass Index
Weight and height will be assessed using a calibrated electronic digital weighing scale and stadiometer respectively
Time frame: Baseline and 4 and 8 months
Change in Waist Circumference
Waist circumference will be assessed using an inelastic measuring tape to the nearest 0.1cm on bare skin
Time frame: Baseline and 4 and 8 months
Change in Systolic Blood Pressure
Resting systolic blood pressure will be assessed
Time frame: Baseline and 4 and 8 months
Change in Diastolic Blood Pressure
Resting diastolic blood pressure will be assessed
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants in the usual care control group will receive health education delivered by research personnel. This program will consist of eight two-hour bi-weekly sessions covering major health issues relating to obesity including causes, prevalence, epidemiology, associated diseases, healthy diet, caloric restriction advice, physical activity, stress management, adequate sleep, as well as lifestyle counseling/consultation and goal-setting/record-keeping strategies for behavioral changes.
Time frame: Baseline and 4 and 8 months
Change in Fasting Glucose
Fasting glucose will be analyzed from venous blood by an accredited medical laboratory
Time frame: Baseline and 4 and 8 months
Change in Fasting Triglycerides
Fasting triglycerides will be analyzed from venous blood by an accredited medical laboratory
Time frame: Baseline and 4 and 8 months
Change in Fasting Low Density Lipoprotein Cholesterol (LDL-C)
Fasting LDL-C will be analyzed from venous blood by an accredited medical laboratory
Time frame: Baseline and 4 and 8 months
Change in Fasting High Density Lipoprotein Cholesterol (HDL-C)
Fasting HDL-C will be analyzed from venous blood by an accredited medical laboratory
Time frame: Baseline and 4 and 8 months
Change in Fasting Total Cholesterol
Fasting total cholesterol will be analyzed from venous blood by an accredited medical laboratory
Time frame: Baseline and 4 and 8 months
Change in Proportion of Metabolic Syndrome Diagnosis
Metabolic syndrome diagnosis will be evaluated with waist circumference, triglycerides, HDL-C, blood pressure, and fasting glucose
Time frame: Baseline and 4 and 8 months
Number of Adverse Events
Adverse events related or unrelated to training will be assessed
Time frame: Baseline and 4 and 8 months
Change in Organ Fat
Organ fat will be assessed using magnetic resonance imaging (MRI)
Time frame: Baseline and 4 and 8 months
Change in SF-12 Physical Component Summary Score
Physical health-related quality of life will be assessed using the Physical Component Summary Score of the 12-Item Short-Form Health Survey (SF-12)
Time frame: Baseline and 4 and 8 months
Change in SF-12 Mental Component Summary Score
Mental health-related quality of life will be assessed using the Mental Component Summary Score of the 12-Item Short-Form Health Survey (SF-12)
Time frame: Baseline and 4 and 8 months
Change in HADS-D Score
HADS-D score will be assessed using the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D)
Time frame: Baseline and 4 and 8 months
Change in PHQ-9 Score
PHQ-9 score will be assessed using the Patient Health Questionnaire-9 (PHQ-9)
Time frame: Baseline and 4 and 8 months
Change in HADS-A Score
HADS-A score will be assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A)
Time frame: Baseline and 4 and 8 months
Change in GAD-7 Score
GAD-7 score will be assessed using the General Anxiety Disorder-7 (GAD-7) Questionnaire
Time frame: Baseline and 4 and 8 months